Sarah Hormachea: Diabetes Care and Education

Sarah Hormachea: Diabetes Care and Education Partnering with healthcare organizations to meet your diabetes care and education needs

Nutrition is the missing link in diabetes care… and virtual dietitians are stepping in.For years, nutrition has been an ...
07/22/2025

Nutrition is the missing link in diabetes care… and virtual dietitians are stepping in.

For years, nutrition has been an essential yet underused part of diabetes care. That’s starting to change.

Virtual dietitians are making nutrition support more accessible, more flexible, and more personal than ever before, meeting people where they are and helping close long-standing gaps in care.

👉 Read it now: https://www.sarahhormachea.com/2025/07/22/how-virtual-dietitians-are-expanding-access-to-diabetes-care/

For years, nutrition support has been an essential but underutilized part of diabetes care. Despite strong evidence that medical nutrition therapy improves outcomes, many people with diabetes have …

One of the most powerful shifts at this year’s   Scientific Sessions was the growing emphasis on weight bias and stigma ...
06/28/2025

One of the most powerful shifts at this year’s Scientific Sessions was the growing emphasis on weight bias and stigma in clinical care.

From stories of lived experience to new clinical guidelines, the message was clear: we can’t improve diabetes outcomes without addressing the harm caused by judgment-based care.

Take a look at a few key takeaways from the discussion on bias in obesity care.
https://www.sarahhormachea.com/2025/06/28/ada-scientific-sessions-expanding-the-discussion-to-include-weight-bias/

This past weekend, I had the pleasure of attending the American Diabetes Association’s 85th Scientific Sessions in Chicago. It was a phenomenal gathering of researchers, clinicians, scientists, and…

06/16/2025

The International Obesity Collaborative, a global alliance of professional organizations focused on improving obesity care, recently released a powerful consensus statement: obesity care and weight…

Obesity care ≠ weight loss.The International Obesity Collaborative recently released a powerful consensus: effective obe...
06/16/2025

Obesity care ≠ weight loss.

The International Obesity Collaborative recently released a powerful consensus: effective obesity care isn’t just about lowering the number on the scale, it’s about improving health, quality of life, and dignity.

As clinicians, we need to shift from “weight loss at all costs” to comprehensive, person-centered care.

Curious about how this changes clinical practice? Read the full breakdown here ⬇️
https://www.sarahhormachea.com/2025/06/16/obesity-care-vs-weight-loss-whats-the-difference/

The International Obesity Collaborative, a global alliance of professional organizations focused on improving obesity care, recently released a powerful consensus statement: obesity care and weight…

Does CGM Tell the Whole Story?I took a second look at Lingo, Abbott’s direct-to-consumer CGM, this time through the lens...
06/11/2025

Does CGM Tell the Whole Story?

I took a second look at Lingo, Abbott’s direct-to-consumer CGM, this time through the lens of metabolic health, behavior change, and coaching—not just hardware and wearability.

I’ve got insights, questions, and a few cautionary flags—especially for those navigating metabolic health without clinical support.

Read the full article here - https://www.sarahhormachea.com/2025/06/11/does-cgm-tell-the-whole-story-a-second-look-at-lingo-for-metabolic-monitoring/

I recently revisited Lingo, Abbott’s direct-to-consumer continuous glucose monitoring (CGM) system, after a new wave of clients began seeking guidance on how to use it to support metabolic health, …

🎓 Congratulations to the Dietetic Internship Class of 2025!Last week, I had the privilege of speaking to the graduating ...
06/03/2025

🎓 Congratulations to the Dietetic Internship Class of 2025!

Last week, I had the privilege of speaking to the graduating interns at Children’s Hospital Colorado—a passionate group of future RDNs ready to make their mark in the world of nutrition and dietetics.

I shared my winding (but worthwhile) path from clinical care to entrepreneurship in diabetes education, and offered a few lessons I’ve learned along the way.

🔗 Read the full article: https://www.sarahhormachea.com/2025/06/03/congratulations-to-the-graduating-class-of-2025/

On May 30th, I had the opportunity to speak to the graduating dietetic interns at Children’s Hospital Colorado, sharing my journey from clinical care to entrepreneurship in diabetes care and educat…

Is it time to say goodbye to BMI?With the rise of GLP-1 therapies, tracking body composition, not just weight, is more i...
05/27/2025

Is it time to say goodbye to BMI?

With the rise of GLP-1 therapies, tracking body composition, not just weight, is more important than ever. From preserving muscle mass to assessing metabolic risk, composition tools are changing the game.

In my latest article, I explore:
✅ Why BMI is no longer enough
✅ How body composition assessments work
✅ Practical tips for integrating them into clinical care
✅ A comparison of my own results using InBody vs. DXA

👉 Read the full article here - https://www.sarahhormachea.com/2025/05/27/goodbye-bmi-why-body-composition-is-gaining-ground-in-clinics/

The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid wei…

GLP-1 success isn’t just about the medication—it’s about the care team behind it.From   to  , incretin-based therapies a...
05/20/2025

GLP-1 success isn’t just about the medication—it’s about the care team behind it.

From to , incretin-based therapies are reshaping obesity care. But long-term success depends on more than prescriptions. In my latest article, I explore why dietitians are essential to every GLP-1 program and how we can drive sustainable, patient-centered outcomes.

👉 Read the full piece: https://www.sarahhormachea.com/2025/05/20/glp-1-success-starts-with-dietitian-leadership/

It should come as no surprise that a large part of the success with incretin-based therapies— like Ozempic, Wegovy, Mounjaro, and Zepbound—stems from the effective integration of lifestyle modifica…

Have you heard of Type 5 diabetes and wondered why it’s suddenly appearing in medical discussions? It’s not entirely new...
05/13/2025

Have you heard of Type 5 diabetes and wondered why it’s suddenly appearing in medical discussions? It’s not entirely new—but it is newly recognized.

Linked to early-life malnutrition and distinct from Type 1, Type 5 diabetes challenges traditional classifications and calls for more tailored, context-specific care.

👉 Read more: https://www.sarahhormachea.com/2025/05/13/what-is-type-5-diabetes-exploring-the-newest-diagnostic-category/

If you’ve seen a new diabetes diagnosis category circulating in medical circles and found yourself confused, thinking, “I don’t remember learning about that type in medical, nursing, or dietetics s…

📱Wearables are no longer just about steps—they’re shaping the future of healthcare.In this new article, I explore how Di...
05/06/2025

📱Wearables are no longer just about steps—they’re shaping the future of healthcare.

In this new article, I explore how Diabetes Care and Education Specialists can lead the charge in integrating wearable tech into chronic disease management. From CGMs to sleep and stress trackers, the opportunities are growing and so is our role.

👉 Read the full article: https://www.sarahhormachea.com/2025/05/06/dces-leadership-in-the-future-of-wearable-health-technology/

In a recent issue of Healthcare150, a newsletter spotlighting key healthcare trends, I was struck by the projected growth of wearable devices—from $14.5 billion in 2020 to $76.1 billion by 2029.In …

GLP-1 Therapy: When Is It Time to Stop?In Part 4 of my GLP-1 series, I dive into the big question: How do we know when (...
04/30/2025

GLP-1 Therapy: When Is It Time to Stop?

In Part 4 of my GLP-1 series, I dive into the big question: How do we know when (or if) it’s time to discontinue therapy?

From weight loss milestones to metabolic markers and lifestyle sustainability, here are 4 key areas to guide your decision-making—and why long-term support may be necessary for many.

👉 Read Part 4: Discontinuation Considerations https://www.sarahhormachea.com/2025/04/30/glp-1-therapy-part-4-navigating-the-decision-to-discontinue/

I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment.This p…

GLP-1 therapy is a powerful tool—but it’s not a standalone solution.In Part 3 of my four-part series, I share nutrition ...
04/22/2025

GLP-1 therapy is a powerful tool—but it’s not a standalone solution.

In Part 3 of my four-part series, I share nutrition strategies to support effective weight loss and long-term success while on GLP-1 medications. From protein and fiber targets to preserving muscle mass through resistance training, this article includes practical tips you can use in practice.

👉 Read Part 3: Strategies for Weight Loss
https://www.sarahhormachea.com/2025/04/22/glp-1-therapy-part-3-strategies-for-successful-weight-loss/

I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment.This p…

Address

Denver, CO

Alerts

Be the first to know and let us send you an email when Sarah Hormachea: Diabetes Care and Education posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Sarah Hormachea: Diabetes Care and Education:

Share